Execute 25-30% trim to 50-60% residual via two tranches; reject Buy/Overweight given binding 9/29 lesson and Hold bucket alpha decay
UNDERWEIGHT with 25-30% trim (binding constraint from 9/29 reflection: zero T1 deployment when overhead resistance, negative MACD, and imminent earnings align). Rejects Research Manager Overweight and trader Buy. The Hold bucket has produced -0.4% to -1.8% alpha decay across 6 prior decisions; the 9/29 near-identical configuration produced -0.5% alpha on -0.7% raw return. 25-30% trim is validated by 9/25 and 9/28 empirical record. Preserves 50-60% residual to compounding structural thesis (margin expansion, $289B backlog, Tomahawk ramp, GTF aftermarket, NATO commitments, nuclear modernization) while escaping the alpha-decaying Hold bucket and avoiding T1 deployment into broken regime four weeks before binary print. Price target $215.
| Position | Action |
|---|---|
| Tranche 1: current prices $185-187 | ~10-12% trim immediate execution |
| Tranche 2: failed-bounce supply zone $190-193 | ~13-18% trim via limit orders |
| Total trim of 25-30% of 80-85% residual | Resulting residual 50-60% of original position |
| Confirmed close below $183.40 (lower Bollinger band) | Escalate: additional 15-20% trim; total residual 35-45% |
| Confirmed close below $178.50 | Hard stop triggered; full exit of remaining position |
RTX at $185.01 represents a high-conviction, low-risk entry where deeply oversold technicals (RSI 24.43, Bollinger lower band, double-bottom retest of April lows) converge with a fundamental inflection that has already delivered 110% net income growth and 530 bps of margin expansion—the bear's "wait for $207" strategy is a 12% tax on returns, not patience.
| Indicator | Value | Signal |
|---|---|---|
| Close | 185.01 | neutral |
| 10 EMA | 189.24 | bearish |
| 50 SMA | 206.79 | bearish |
| 200 SMA | 193.79 | bearish |
| RSI(14) | 24.43 | bearish |
| MACD | -5.48 | bearish |
| MACD Signal | -4.96 | bearish |
| MACD Histogram | -0.52 | bearish |
| Bollinger Middle | 193.55 | neutral |
| Bollinger Upper | 203.71 | neutral |
| Bollinger Lower | 183.40 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Binary event resolution
Then: Maintain Underweight; reassess after 10 sessions
RTX is tracing a double-bottom formation at the April lows with deeply oversold RSI, not trend continuation
↩ rebuts: “Bear's 'Trend alignment is fully negative' and 'in strong downtrends RSI can stay below 30 for extended periods'”
EV: +5.7% · concedes: MACD is still negative and momentum hasn't rolled; The 10 EMA at 189.24 (+2.3% from current) is the fastest but noisiest signal; Receivables up 34% YoY warrants monitoring; Trend is currently down; A close above 189.24 from current levels gives up margin of safety for almost no additional information
Do not initiate long exposure ahead of Q3 earnings; the bull's $185 entry is a "knife catch" at maximum uncertainty with unresolved balance-sheet questions, deteriorating technicals, and a single catalyst (Q3 print in late October) that will resolve all open questions in one session.
EV: +0.5% · concedes: The bull's long-term fundamental improvement is real (net income +110%, operating margin +530 bps, FCF +58%, net debt cut in half); The PEG argument would be valid if consensus holds; The 5.81% dividend yield is real income while waiting; Defense is structurally a good sector with NATO 3%, Indo-Pacific posture, Ukraine munitions demand; The sentiment vacuum does not necessarily mean bearish — could be neutral or accumulation; Both analysts could be right about long-term direction; the bear's advantage is losing less on the wrong path; The 5.81% yield is being paid while waiting for confirmation — though it 'evaporates' on consensus disappointment
→ vs conservative: Waiting for daily close above 50 SMA at $206.79 requires forfeiting ~11.5% upside to confirm what RSI at 24.43 already indicates; MACD is a lagging momentum oscillator that will turn AFTER price moves, meaning the conservative plan asks to buy at $200 instead of $185
→ vs conservative: MACD histogram widening is indicator-enslavement, not risk management; the conservative plan requires MACD confirmation after missing the optimal entry
→ vs neutral: Forward P/E of 23.6x is not expensive for a business at earnings inflection with 110% net income growth, 530 bps margin expansion, and near-doubled FCF of $7.45B
→ vs neutral: 34% YoY receivables increase to $14.7B is a structural defense billing cycle feature, not a credit risk; current ratio of 1.011 is a feature of defense primes, and $21.6B deferred liabilities represent customer-funded pre-paid backlog
→ vs neutral: Zero news flow and zero retail interest at oversold technicals with 0.287 beta and 5.81% forward cash yield is a gift, not a warning; light positioning means violent re-rating when Q3 FCF and GTD aftermarket commentary hit
→ vs conservative: The conservative analyst is asking to give up the best risk-adjusted entry window in months to buy 11% higher with worse risk-reward
→ vs conservative: Three scenarios support the stock: (1) meets consensus and mean-reverts to 50 SMA, (2) beats consensus in early-cycle defense capex boom (double tailwind), (3) European defense spending accelerates beyond NATO 3% targets (geopolitical premium repricing)
| bullish |
| ATR(14) | 3.73 | neutral |
| VWMA | 191.46 | bearish |
Support: 183.4 · 170.5 · 172.09 | Resistance: 189.24 · 193.55 · 193.79 · 203.71 · 206.79
Bearish downtrend confirmed with full cascade alignment: Price < 10 EMA (189.24) < 200 SMA (193.79) < 50 SMA (206.79). MACD line (-5.48) below signal (-4.96) with widening histogram (-0.52) indicates accelerating downside momentum. RSI at 24.43 is deeply oversold but can remain so in strong downtrends. Price is sitting just above the Bollinger lower band (185.01 vs 183.40), with only ~$1.60 cushion — a daily close below 183.40 would confirm volatility expansion. VWMA at 191.46 confirms sellers controlling volume. Support zones: 183.40 (lower band) → 170.50–172.09 (April lows). Resistance: 189.24 (10 EMA) reclaim needed for stabilization, 193.55 (Bollinger middle) for mean-reversion, 206.79 (50 SMA) for trend reversal confirmation.
Market Capitalization
$249.35B
Share Price
~$185.09
52-Week High
$226.88
52-Week Low
$155.64
50-Day Moving Average
$207.21
200-Day Moving Average
$194.87
Beta
0.287
Dividend Yield
1.57%
P/E (TTM)
32.57
Forward P/E
23.56
PEG Ratio
2.15
P/B Ratio
3.76
Book Value per Share
$49.25
Revenue (2025)
$88.60B
Revenue (2024)
$80.74B
Revenue (2023)
$68.92B
Revenue (2022)
$67.07B
Gross Profit (2025)
$17.79B
Operating Income (2025)
$9.30B
EBITDA Normalized (2025)
$14.95B
Net Income (2025)
$6.73B
Net Income (2024)
$4.77B
Net Income (2023)
$3.20B
Diluted EPS (2025)
$4.96
Diluted EPS (2024)
$3.55
Diluted EPS (2023)
$2.23
Gross Margin (2025)
20.1%
Operating Margin (2025)
10.5%
Operating Margin (2023)
5.2%
Effective Tax Rate (2025)
19.1%
R&D Spend (2025)
$2.81B
Total Assets (2025)
$171.08B
Total Debt (2025)
$39.51B
Total Debt (2023)
$45.24B
Net Debt (2025)
$30.47B
Stockholders Equity (2025)
$65.25B
Goodwill Intangibles (2025)
$85.19B
Net PPE (2025)
$18.76B
Inventory (2025)
$13.36B
Accounts Receivable (2025)
$14.70B
Accounts Receivable (2024)
$10.98B
Cash Equivalents (2025)
$7.44B
Working Capital (2025)
$1.55B
Current Ratio (2025)
1.011
Debt Equity (2025)
0.61
Net Debt EBITDA (2025)
~2.0x
Operating Cash Flow (2025)
$10.57B
Capital Expenditures (2025)
$3.12B
Free Cash Flow (2025)
$7.45B
Free Cash Flow (2024)
$3.92B
Acquisitions Disposals (2025)
$1.93B
Dividends Paid (2025)
$3.57B
Net Debt Issuance Repayment (2025)
$3.43B
Share Repurchases (2025)
$0.05B
Share Repurchases (2023)
$12.87B
End Cash Position (2025)
$7.44B
Revenue Growth (2025)
+9.7%
Revenue Growth (2024)
+17.1%
Net Income Growth (2025)
+41.0%
Net Income Growth (2024)
+49.3%
Revenue CAGR (4-year)
~9.7%
EPS Growth (2023 to 2025)
+122%
ROE (2025)
12.27%
ROA (2025)
4.21%
FCF Margin (2025)
8.4%
Dividend Coverage FCF Div (2025)
2.09x
Interest Expense (2025)
$1.84B
Goodwill
$53.3B
Forward EPS Consensus
$7.85
TTM EPS
$5.68
Receivables YoY Growth
+34%
Operating Cash Flow Growth (2025)
+47.6%
Strengths
Concerns
RTX Corporation is a high-quality aerospace and defense prime in the middle of an earnings inflection and balance sheet repair. Revenue grew at a 4-year CAGR of approximately 9.7% with net income more than doubling from $3.20B in 2023 to $6.73B in 2025, while operating margins expanded 530 bps from the 2023 trough of 5.2% to 10.5% in 2025. The fundamental story is intact with backlog strength from missile demand, GTF aftermarket recovery, European rearmament tailwinds, and disciplined capital allocation, but valuation appears full at a Forward P/E of 23.6x with the stock trading below both its 50-day and 200-day moving averages.
Macro: Hawkish regime with 97% probability of zero Fed rate cuts in 2026; 10Y Treasury yield at highest since 2002 (biggest monthly gain since 2022); US recession odds 8% and declining; Fed officials publicly warning inflation still too high; broad equity rebound on Oct 1 as yields fell and chip stocks rallied (risk-on); Turkey/F-35 re-engagement odds sharply declining; cybersecurity and IT services stocks rallying on strong outlook (adjacent beneficiaries of defense/security spending uplift).